Showing results (371-380 of 892) with videos related to

Sort By:
Pageof 90
The Journal of Nervous and Mental Disease|April 12, 2016
Association of Spirituality With Mental Health Conditions in Ohio National Guard SoldiersStephen J Ganocy, Toyomi Goto, Philip K Chan, et al.
The American Journal on Addictions|February 20, 2016
A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorderLouisa G Sylvia, Alexandra K Gold, Jonathan P Stange, et al.
Journal of Affective Disorders|December 11, 2012
Age differences in the phenomenology of pediatric bipolar disorderChristine A Demeter, Eric A Youngstrom, Gabrielle A Carlson, et al.
The Journal of Clinical Psychiatry|April 29, 2003
Impact of bipolar disorder on a U.S. community sampleJoseph R Calabrese, Robert M A Hirschfeld, Michael Reed, et al.
The Journal of Clinical Psychiatry|December 14, 2011
Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorderRobert L Findling, Eric A Youngstrom, Nora K McNamara, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 23, 2003
Combination lithium and divalproex sodium in pediatric bipolarityRobert L Findling, Nora K McNamara, Barbara L Gracious, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 20, 2021
Lung transplant recipients with idiopathic pulmonary fibrosis have impaired alloreactive immune responsesPing Wang, Joey Leung, Alice Lam, et al.
JCI Insight|October 16, 2019
Dectin-1 genetic deficiency predicts chronic lung allograft dysfunction and deathDaniel R Calabrese, Ping Wang, Tiffany Chong, et al.
The Journal of Clinical Psychiatry|July 15, 2005
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorderTrisha Suppes, Ellen B Dennehy, Robert M A Hirschfeld, et al.
The Journal of Clinical Psychiatry|February 2, 2017
Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal StudyJoseph R Calabrese, Raymond Sanchez, Na Jin, et al.
Pageof 90